Request Information

Premier Perspectives

The blog for insider insights in clinical development

COVID-19

Leveraging Emergency Use Authorizations to Bring COVID-19 Products to Market

By

May 7, 2020

Featured Posts

Learn more about the latest events and updates.

COVID-19

Data Driven: How Electronic Patient-Reported Outcomes (ePROs) Provide a Vital Opportunity to Capture Key Data Beyond the COVID-19 Crisis

By

April 30, 2020

COVID-19

PREMIER VOICES #10: COVID-19 Update – How the FDA's Emergency Use Authorization Can Help Develop Therapies Faster

By

April 7, 2020

Recent Posts

Learn more about the latest events and updates.

COVID-19

PREMIER VOICES #9: COVID-19 Update – What Sponsors Need to Know About the New FDA Guidance

By

March 31, 2020

COVID-19

What Is FDA’s Emergency Use Authorization (EUA) and How Can It Help Develop Therapies Faster?

By

March 20, 2020

COVID-19

FDA Issues Guidance on Clinical Trials During COVID-19

By

March 20, 2020

Consulting

FAQ: How the EU Medical Devices Regulation Affects Existing Products

By

May 8, 2019

Medical and Regulatory Affairs

The Evolution of Regulations for Digital Health Products

By

November 5, 2018

Consulting

Sponsors and CROs get More Clarity on Precision, Targeted Therapy Trials

By

January 3, 2018